NCT00311012View on ClinicalTrials.gov

SPP100 Dose Finding Study in Japan

PHASE2CompletedINTERVENTIONAL

Enrollment

445

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions

Hypertension

Interventions

DRUG

Aliskiren

Trial Locations (1)

Unknown

Novartis Pharmaceuticals, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY